http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6478302ad901b88a7ea228ed5a904863
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Cohen |
| name | Martin H Cohen Martin H. Cohen |
| given-name | Martin H Martin H. |
| organization-name | a Office of Oncology Drug Products, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA Division of Oncology Drug Products, Center for Drug Evaluation and Research, United States Food and Drug Administration, Rockville, Maryland NCI‐VA Medical Oncology Brand, Division of Cancer Treatment, National Cancer Institute, Washington VA Medical Center, Washington, D. C. Division of Oncology Drug Products (HFD-150), Center for Drug Evaluation and Research and Office of Orphan Products Development, Office of the Commissioner, Food and Drug Administration, Rockville, Maryland, USA Office of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA Division of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland, USA Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, Maryland, USA Division of Oncology Drug Products (HFD-150), Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20857, USA. cohenm@cder.fda.gov Division of Drug Oncology Products, Office of Oncology Drug Products, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA From the Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland; The NCI-VA Medical Oncology Service, Veterans Administration Medical Center, Washington, D. C. Office of Hematology Oncology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA Authors' Affiliation: Division of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland Authors' Affiliation: Division of Drug Oncology Products, Office of Oncology Drug Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland Division of Biological Oncology Products, Office of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA Division Oncology Drug Products, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20857, USA. cohenm@cder.fda.gov Division of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, Maryland 20993, USA. |
Incoming Links
Total number of triples: 127.